P3.01-035 Post-Marketing Observational Study of Japanese Patients with EGFR Mutation-Positive (EGFRm+) NSCLC Treated with Daily Afatinib (Final Report)
Autor: | Yamamoto, N., Nukiwa, T., Nakanishi, Y., Gemma, A., Mizushima, M., Takayama, T., Kumazawa, J., Azuma, H., Tamura, K. |
---|---|
Zdroj: | In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S2213-S2214 |
Databáze: | ScienceDirect |
Externí odkaz: |